Evidence map›Paper›PMID 42111529›Full record

ArticleRSC advances2026

Synthesis, cholinesterase/MAO-A inhibition, antioxidant potential and detailed computational analysis of 3,5-difluorobenzenesulfonate-tagged ethoxyvanillin hydrazones.

Arooj Fatima, Faiqa Noreen, Halil Şenol, Parham Taslimi, Mostafa A Ismail, Rima D Alharthy, Asif Rasool, Magdi E A Zaki, Sobhi M Gomha, Zahid Shafiq

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arooj FatimaInstitute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan.
Faiqa NoreenInstitute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan.
Halil ŞenolDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University 34093 Fatih Istanbul Turkiye zahidshafiq@bzu.edu.pk.
Parham TaslimiDepartment of Biotechnology, Faculty of Science, Bartin University 74110 Bartin Turkiye.
Mostafa A IsmailResearch Center for Advanced Materials Science (RCAMS), Chemistry Department, Faculty of Science, King Khalid University P. O. Box 960 Abha 61413 Saudi Arabia.
Rima D AlharthyDepartment of Chemistry, Science & Arts College, Rabigh Branch, King Abdulaziz University Rabigh 21911 Saudi Arabia.
Asif RasoolSchool of Chemistry and Chemical Engineering Nanjing University Nanjing 210093 China.
Magdi E A ZakiDepartment of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 11623 Saudi Arabia.
Sobhi M GomhaDepartment of Chemistry, Faculty of Science, Islamic University of Madinah Madinah 42351 Saudi Arabia smgomha@iu.edu.sa.ORCID https://orcid.org/0000-0002-7739-2837
Zahid ShafiqInstitute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan.ORCID https://orcid.org/0000-0003-4088-8297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new series of hydrazones were prepared and assessed for their inhibitory activity against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidase-A (MAO-A) along with their antioxidant activity. Among the tested compounds, 5i displayed the maximum inhibitory activity with IC

Identifiers

PMID42111529
PMCPMC13155080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.